Inventor · disambiguated record
Magnus Pfahl
Also filed as: PFAHL MAGNUS
24 granted patents·7 pending applications·434 citations·filing 1990–2006
96Inventor score
Files withJOLLA CANCER RES FOUND5ORTHO MCNEIL PHARM INC5BURNHAM INST4GALDERMA RES & DEV3PFAHL MAGNUS3
Top patents by PatentIndex Score
31 records- 0197US5466861ABridged bicyclic aromatic compounds and their use in modulating gene expression of retinoid receptorsSTANFORD RES INST INT·Filed 1992·Granted Nov 14, 1995·168 cites·23 claims
- 0290US6765013B2Thiazolidinedione derivatives for the treatment of diabetes and other diseasesINCYTE SAN DIEGO·Filed 2002·Granted Jul 20, 2004·37 cites·32 claims
- 0389US6515003B1Heterocyclic derivatives for the treatment of diabetes and other diseasesMAXIA PHARMACEUTICALS INC·Filed 2000·Granted Feb 4, 2003·42 cites·23 claims
- 0487US6462064B1Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasiasGALDERMA RES & DEV·Filed 2000·Granted Oct 8, 2002·25 cites·42 claims
- 0580US7226940B2Substituted heterocycles for the treatment of diabetes and other diseasesORTHO MCNEIL PHARM INC·Filed 2005·Granted Jun 5, 2007·3 cites·20 claims
- 0678US7153875B2Heterocyclic derivatives for the treatment of cancer and other proliferative diseasesINCYTE SAN DIEGO·Filed 2002·Granted Dec 26, 2006·13 cites·9 claims
- 0778US7102000B2Heterocyclic amide derivatives for the treatment of diabetes and other diseasesORTHO MCNEIL PHARM INC·Filed 2003·Granted Sep 5, 2006·9 cites·77 claims
- 0878US5552271ARXR homodimer formationJOLLA CANCER RES FOUND·Filed 1992·Granted Sep 3, 1996·15 cites·4 claims
- 0977US7071218B2N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseasesORTHO MCNEIL PHARM INC·Filed 2002·Granted Jul 4, 2006·10 cites·45 claims
- 1074US6974826B2Imidazolidinedione derivatives for the treatment of diabetes and other diseasesORTHO MCNEIL PHARM INC·Filed 2004·Granted Dec 13, 2005·5 cites·32 claims
- 1174US6127415AApoptosis inducing adamantyl derivatives and their usage as anti-cancer agentsGALDERMA RES & DEV·Filed 1997·Granted Oct 3, 2000·41 cites·96 claims
- 1271US7196108B2Bicyclic heterocycles for the treatment of diabetes and other diseasesORTHO MCNEIL PHARM INC·Filed 2003·Granted Mar 27, 2007·7 cites·61 claims
- 1371US6825226B2Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasiasGALDERMA RES & DEV·Filed 2002·Granted Nov 30, 2004·2 cites·10 claims
- 1461US5837725ABridged bicyclic aromatic compounds and their use in modulating gene expression of retinoid receptorsSTANFORD RES INST INT·Filed 1995·Granted Nov 17, 1998·8 cites·32 claims
- 1554US5712093ARXR homodimer formationBURNHAM INST·Filed 1994·Granted Jan 27, 1998·3 cites·8 claims
- 1654US5144007AThyroid hormone receptorJOLLA CANCER RES FOUND·Filed 1990·Granted Sep 1, 1992·11 cites·4 claims
- 1751US5824484ARXR homodimer formationJOLLA CANCER RES FOUND·Filed 1996·Granted Oct 20, 1998·10 cites·11 claims
- 1850US2006160796A1N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseasesPFAHL MAGNUS·Filed 2006·Application pending·0 cites
- 1948US2006241138A1Heterocyclic amide derivatives for the treatment of diabetes and other diseasesPFAHL MAGNUS·Filed 2006·Application pending·0 cites
- 2047US2005209286A1RXR activating moleculesPFAHL MAGNUS·Filed 2005·Application pending·0 cites
- 2145US5183736AMethods using estrogen receptor as a constitutive transcriptional activator and a repressorJOLLA CANCER RES FOUND·Filed 1990·Granted Feb 2, 1993·15 cites·17 claims
- 2242US2005038098A1Substituted dihydronaphthalene and isochroman compounds for the treatment of metabolic disorders, cancer and other diseasesFiled 2004·Application pending·0 cites
- 2342US2003083357A1Oxime derivatives for the treatment of dyslipidemia and hypercholesteremiaFiled 2002·Application pending·0 cites
- 2438US6683047B1Method of inhibiting transcription utilizing nuclear receptorsBURNHAM INST·Filed 1998·Granted Jan 27, 2004·1 cites·1 claims
- 2538US2004097566A12-Substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancerFiled 2002·Application pending·0 cites
- 2638US2005014767A1Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseasesFiled 2004·Application pending·0 cites
- 2736US6335159B1Retinoic acid receptor ε(rarε)BURNHAM INST·Filed 1993·Granted Jan 1, 2002·4 cites·1 claims
- 2834US5643720AMethod of inhibiting transcription utilizing nuclear receptorsBURNHAM INST·Filed 1994·Granted Jul 1, 1997·4 cites·5 claims
- 2932US6004748AMethod of inhibiting transcription utilizing nuclear receptorsJOLLA CANCER RES FOUND·Filed 1996·Granted Dec 21, 1999·1 cites·22 claims
- 3031US7026125B1Heterodimers of retinoid X receptors (RXRS) and other steroid hormone receptorsLIGAND PHARMACEUTICALS·Filed 1999·Granted Apr 11, 2006·0 cites·26 claims
- 3128US7098310B1Heterodimers of retinoid X receptors (RXRS) and other steroid hormone receptorsLIGAND PHARMACEUTICALS·Filed 1991·Granted Aug 29, 2006·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Magnus Pfahl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →